Dr. Padmanee Sharma on the Evolving Landscape of Immune Response and PD-L1 as an Ineffective Biomarker

January 11, 2016
Padmanee Sharma, MD, PhD

Padmanee Sharma discusses the constantly shifting landscape of immune response and how it differs from patient to patient. Sharma says in order to best treat a patient with bladder cancer, oncologists have to consider that immune response in patients will never be the same day to day.

Padmanee Sharma, MD, PhD, professor of Immunology, MD Anderson Cancer Center, discusses the constantly shifting landscape of immune response and how it differs from patient to patient. Sharma says in order to best treat a patient with bladder cancer, oncologists have to consider that immune response in patients will never be the same day to day.